CN105106068B - Calm the nerves perfume - Google Patents
Calm the nerves perfume Download PDFInfo
- Publication number
- CN105106068B CN105106068B CN201510576560.6A CN201510576560A CN105106068B CN 105106068 B CN105106068 B CN 105106068B CN 201510576560 A CN201510576560 A CN 201510576560A CN 105106068 B CN105106068 B CN 105106068B
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- extraction
- essential oil
- perfume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002304 perfume Substances 0.000 title claims abstract description 45
- 210000005036 nerve Anatomy 0.000 title claims abstract description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 47
- 239000000341 volatile oil Substances 0.000 claims abstract description 45
- 241000411851 herbal medicine Species 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 23
- 230000001914 calming effect Effects 0.000 claims abstract description 23
- 239000012153 distilled water Substances 0.000 claims abstract description 21
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 20
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000661 sodium alginate Substances 0.000 claims abstract description 17
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 17
- -1 pyrrolidone sodium carboxylate Chemical class 0.000 claims abstract description 15
- 238000010521 absorption reaction Methods 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000003623 enhancer Substances 0.000 claims abstract description 12
- 235000011187 glycerol Nutrition 0.000 claims abstract description 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims description 42
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 229920001661 Chitosan Polymers 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 16
- 239000001569 carbon dioxide Substances 0.000 claims description 15
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 15
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 241000271309 Aquilaria crassna Species 0.000 claims description 11
- 244000247747 Coptis groenlandica Species 0.000 claims description 11
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 11
- 235000011201 Ginkgo Nutrition 0.000 claims description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 11
- 244000242564 Osmanthus fragrans Species 0.000 claims description 11
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims description 11
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 11
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 11
- 240000007164 Salvia officinalis Species 0.000 claims description 11
- 235000005412 red sage Nutrition 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 241000005787 Cistanche Species 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 244000111489 Gardenia augusta Species 0.000 claims description 8
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 244000292697 Polygonum aviculare Species 0.000 claims description 8
- 235000006386 Polygonum aviculare Nutrition 0.000 claims description 8
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 8
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 8
- 240000006079 Schisandra chinensis Species 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 241001643874 Cymbopogon distans Species 0.000 claims description 7
- 244000246386 Mentha pulegium Species 0.000 claims description 7
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 7
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 235000001050 hortel pimenta Nutrition 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 4
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 4
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 238000006392 deoxygenation reaction Methods 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- 244000290333 Vanilla fragrans Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 abstract description 12
- 230000036506 anxiety Effects 0.000 abstract description 9
- 239000003205 fragrance Substances 0.000 abstract description 6
- 230000004630 mental health Effects 0.000 abstract description 3
- 230000036651 mood Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 25
- 239000003814 drug Substances 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 241000218628 Ginkgo Species 0.000 description 9
- 206010070834 Sensitisation Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000008313 sensitization Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000010998 test method Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 235000013599 spices Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- KYDXWCHDUCDNGR-UHFFFAOYSA-N 1-chloro-2,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Cl)=C1[N+]([O-])=O KYDXWCHDUCDNGR-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000013642 negative control Chemical group 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000049 anti-anxiety effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000012346 open field test Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 150000003235 pyrrolidines Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 241000336316 Cistanche tubulosa Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 150000004265 D-glucosamines Chemical class 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000577979 Peromyscus spicilegus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001661920 Telosma Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- WAQGCDLKIUXESA-UHFFFAOYSA-N [P].C1=CC=CC=C1 Chemical compound [P].C1=CC=CC=C1 WAQGCDLKIUXESA-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000020470 nervous system symptom Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
- The perfume 1. one kind is calmed the nerves, it is characterised in that:Raw material by calm the nerves Chinese herbal medicine acquisition essential oil, ethanol, glycerine, distilled water, Sodium alginate, Chinese herbal medicine absorption enhancersN- octyl group chitosan, hydroxypropyl methyl cellulose and pyrrolidone sodium carboxylate are formed;The parts by weight of the parts by weight of parts by weight of essential oil 3~6 of the Chinese herbal medicine acquisition of calming the nerves, the parts by weight of ethanol 15~25, the weight of glycerine 2 Measure the parts by weight of the parts by weight of the parts by weight of part~5, the parts by weight of distilled water 95~105, the parts by weight of sodium alginate 1~3, Chinese herbal medicine promotees to absorb The parts by weight of the parts by weight of parts by weight of agent 0.5~1.5, the parts by weight of hydroxypropyl methyl cellulose 0.5~1.5, pyrrolidone sodium carboxylate 3~ 6 parts;The raw material of the Chinese herbal medicine of calming the nerves is by ginkgo leaf, agalloch eaglewood, rhizoma Gastrodiae, the fruit of Chinese magnoliavine, cape jasmine, dried orange peel, cymbopogon distans, saline cistanche, liter Fiber crops, bean cotyledon perfume, sweet osmanthus, night fragrant flower, giant knotweed, the coptis, the vine of multiflower knotweed, the red sage root, peppermint are formed.
- 2. perfume as claimed in claim 1 of calming the nerves, it is characterised in that:It is describedNThe preparation method of-octyl group chitosan is specially: Chitosan 100g is weighed, the in the mixed solvent of acetic acid and 2L methanol that 2L concentration is 2% is dissolved in, stirs 12h at room temperature, it is thoroughly molten Swollen to be uniformly dispersed, nitrogen deoxygenation 15min adds octanal 200ml, and reaction 12h systems add 6L ethanol after becoming sticky, continue room The lower stirring 48h of temperature, reaction solution is adjusted to neutrality with 1mol/L potassium hydroxide, it is water-soluble using 50g potassium borohydrides configuration alkalescent afterwards Liquid 60ml, is added drop-wise in reaction bulb with dropping funel, continues to be stirred at room temperature 24h, final reaction liquid with 1mol/L hydrochloric acid adjust to Neutrality, product filters, and is washed respectively 3 times with water, methanol, acetone, collects product and finally claims in 30 DEG C of vacuum thorough dry 2 Volume production thing, is obtainedN- octyl group chitosan.
- 3. the preparation method for perfume of calming the nerves described in claim 1 or 2, it is characterised in that including:The first step, sodium alginate is added in the distilled water of part, is heated to 65 DEG C, stirred in insulation, until sodium alginate It is dissolved completely in water, the amount of the distilled water used per 5g sodium alginates is 100ml;Second step, said herbal medicine composition is mixed, Chinese herbal medicine essential oil is extracted and purified by extraction element, collect essence Oil;3rd step, essential oil and Chinese herbal medicine absorption enhancers prepared by second step are dissolved in above-mentioned ethanol dissolving, stirred to complete Fully dissolved;4th step, sodium alginate aqueous solution prepared by the first step, the ethanol solution of the 3rd step preparation, glycerine, hydroxypropyl first Base cellulose and pyrrolidone sodium carboxylate are added in the distilled water of surplus, are stirred, and after standing 37 hours, are put into sealing container In, after being aged 6 weeks, you can.
- 4. the preparation method for perfume of calming the nerves described in claim 3, it is characterised in that:The second step further comprises,2.1st step, sweet osmanthus and night fragrant flower are respectively crushed into coarse powder, mix, using carbon dioxide supercritical extraction, extraction 33~35MPa of pressure, 40~43 DEG C, 110~130min of extraction time of extraction temperature, collect the first essential oil;2.2nd step, ginkgo leaf, rhizoma Gastrodiae, cloud vanilla are respectively crushed into coarse powder, mixed, extracted using CO 2 supercritical Take, 22~25MPa of extracting pressure, 28~32 DEG C, extraction time 160-180min of extraction temperature, collect the second essential oil;2.3rd step, agalloch eaglewood, bean cotyledon perfume, the coptis, the red sage root are ground into coarse powder, using carbon dioxide supercritical extraction, extracting pressure 26 ~30MPa, 45~48 DEG C, 180~200min of extraction time of extraction temperature, collect the 3rd essential oil;2.4th step, remaining components are respectively crushed into coarse powder, mixed, using carbon dioxide supercritical extraction, extraction pressure 24~27MPa of power, 51~54 DEG C, 200~220min of extraction time of extraction temperature, collect the 4th essential oil;2.5th step, above-mentioned essential oil is mixed, it is standby.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510576560.6A CN105106068B (en) | 2015-09-11 | 2015-09-11 | Calm the nerves perfume |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510576560.6A CN105106068B (en) | 2015-09-11 | 2015-09-11 | Calm the nerves perfume |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105106068A CN105106068A (en) | 2015-12-02 |
CN105106068B true CN105106068B (en) | 2018-02-09 |
Family
ID=54654357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510576560.6A Active CN105106068B (en) | 2015-09-11 | 2015-09-11 | Calm the nerves perfume |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105106068B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106137833A (en) * | 2016-07-14 | 2016-11-23 | 唐虎 | The preparation method of perfume |
CN111249181B (en) * | 2019-10-11 | 2020-12-25 | 深圳市越昌科技有限公司 | Long-acting slow-release perfume and preparation method thereof |
CN113181414A (en) * | 2021-01-25 | 2021-07-30 | 福建路合环保科技有限公司 | Natural odor-expelling agent and preparation method and application thereof |
CN113082184A (en) * | 2021-04-08 | 2021-07-09 | 安徽宝华药业有限公司 | Traditional Chinese medicine composition for resisting cancer and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129316A (en) * | 2007-08-30 | 2008-02-27 | 中国热带农业科学院热带生物技术研究所 | Ligaloes perfumes and method of producing the same |
CN101396563A (en) * | 2008-11-06 | 2009-04-01 | 中国药科大学 | Chitose derivates using octreotide as target ligand and use thereof in medicament |
CN103622866A (en) * | 2013-06-30 | 2014-03-12 | 金玛瑙香水(明光)有限公司 | Perfume capable of whitening and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103372178B (en) * | 2012-04-12 | 2014-10-22 | 王海涛 | Medicament and preparation method thereof |
-
2015
- 2015-09-11 CN CN201510576560.6A patent/CN105106068B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129316A (en) * | 2007-08-30 | 2008-02-27 | 中国热带农业科学院热带生物技术研究所 | Ligaloes perfumes and method of producing the same |
CN101396563A (en) * | 2008-11-06 | 2009-04-01 | 中国药科大学 | Chitose derivates using octreotide as target ligand and use thereof in medicament |
CN103622866A (en) * | 2013-06-30 | 2014-03-12 | 金玛瑙香水(明光)有限公司 | Perfume capable of whitening and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN105106068A (en) | 2015-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghazanfar | Arabian medicinal plants | |
CN103041173B (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
CN105106068B (en) | Calm the nerves perfume | |
CN104623178A (en) | Traditional Chinese medicine parasite-expelling reagent and applications thereof | |
CN105106038A (en) | Perfume containing traditional Chinese medicine components and preparation method | |
CN103751633A (en) | Traditional Chinese medicinal composition for treating varicose vein of lower limb and preparation method thereof | |
KR20130113729A (en) | The functional beauti-pacl and its manufacturing method | |
CN108685769A (en) | A kind of herbal mixture black hair anticreep shampoo and preparation method thereof | |
CN104499071A (en) | Traditional Chinese medicine anthelmintic auxiliary agent and application thereof | |
CN104451927B (en) | A kind of Chinese medicine expelling parasite additive and application thereof | |
CN105106318B (en) | A kind of Chinese medicine composition and preparation method thereof for treating xerophthalmia | |
CN105106092A (en) | Chinese herbal perfume capable of relieving fatigue and preparation method | |
CN108853356A (en) | A kind of man is delayed spray and preparation method thereof | |
KR102152752B1 (en) | Aromatic composition containing extract of korean fir for psychological relaxation | |
CN104922051A (en) | Traditional Chinese medicine eye cream capable of relieving canthus wrinkles and eye pouches and preparation method thereof | |
CN101836920A (en) | Far infrared active oxygen & anion sanitary towel and sanitary pad | |
Valnet | Essential Oils and Aromatherapy | |
CN103721138B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating rosacea | |
CN109745404A (en) | A kind of anti-visual fatigue and the Essence for nursing periocualr skin | |
CN104888158A (en) | Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof | |
CN101991520A (en) | Washing-free bath cream with sleeping function and preparation method thereof | |
CN101869616A (en) | Hair nourishing liquid and manufacturing method thereof | |
CN104206444B (en) | A kind of electric liquid device fragrant containing lavender natural and preparation method | |
CN110051744B (en) | Compound traditional Chinese medicine essential oil for treating insomnia | |
CN104695034B (en) | Traditional Chinese medicine mosquito expelling composition and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Nerve soothing perfume Effective date of registration: 20181228 Granted publication date: 20180209 Pledgee: Mingguang Company limited by guarantee financing Pledgor: GOLD ONYX PERFUME (MINGGUANG) Co.,Ltd. Registration number: 2018340000773 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200109 Granted publication date: 20180209 Pledgee: Mingguang Company limited by guarantee financing Pledgor: GOLD ONYX PERFUME (MINGGUANG) Co.,Ltd. Registration number: 2018340000773 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Soothing perfume Effective date of registration: 20231201 Granted publication date: 20180209 Pledgee: Mingguang Company limited by guarantee financing Pledgor: GOLD ONYX PERFUME (MINGGUANG) Co.,Ltd. Registration number: Y2023980068976 |